Skip to main content

Table 6 Pooled effect size of circ_0002052 on osteosarcoma

From: Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis

Clinicopathologic and prognostic parameters

Number of studies

Number of patients

Effect size

Heterogeneity

Sensitivity analysis

Publication bias

OR/HR

95%CI

p value

I-square (%)

chi-square (p)

Begg (p)

Egger (p)

Age

3

146

1.915

0.959–3.826

0.066

0.0%

0.889

Reliable

0.602

0.944

Gender

3

146

0.697

0.364–1.335

0.276

20.6%

0.284

Reliable

0.602

0.645

Tumor site

3

146

0.709

0.348–1.441

0.342

0.0%

0.960

Reliable

0.117

0.145

Tumor size

3

146

1.101

0.235–5.157

0.903

78.6%

0.009

Not Reliable

0.602

0.387

Clinical stage

3

146

3.016

0.599–15.169

0.181

75.9%

0.016

Not Reliable

0.602

0.249

Differentiation grade

2

106

0.130

0.254–1.192

0.130

0.0%

0.502

NA

0.317

NA

Metastasis

3

146

2.290

0.185–28.348

0.519

90.1%

<0.001

Not Reliable

0.602

0.821

Overall survival

3

146

3.197

2.054–4.976

<0.001

0.0%

0.776

Reliable

0.602

0.825

  1. CI confidence interval, HR hazard ratio, OR odds ratio